Listen

LISTEN: Painkiller racketeering, the limits of genetic tests, and pharma’s day on the Hill

[ad_1] Is pharma about to have its Big Tobacco moment? Are we overestimating human genetics? And can sales reps rap? We discuss all that and more on the latest episode...

Read more
LISTEN: The AI hype machine, ketamine’s future, and the rocky path ahead for NASH

[ad_1] When will AI replace your radiologist? What can pharma learn from ketamine? And is liver disease more complicated than anyone thought? We discuss all that and more on the...

Read more
LISTEN: A bad day for bold biotech, campaign 2020, and where do drugs come from?

[ad_1] Are we underestimating biology? Will Hot 97 decide the presidency? And who owns the scientific means of production? We discuss all that and more on the latest episode of...

Read more
LISTEN: Another Alzheimer’s setback, crypto for biotech, and a blessing of unicorns

[ad_1] Is the drug industry wrong about Alzheimer’s disease? Can cryptocurrency fund actual science? And should you feel sorry for Big Pharma? We discuss all that and more on the...

Read more
What to Listen for & Ask at Your Tummy Tuck Consultation

[ad_1] Your tummy tuck consultation is one of the most important steps before your actual procedure. Take your time when choosing a plastic surgeon or two with whom to schedule...

Read more
LISTEN: CRISPR upheaval, Celgene’s chutzpah, and canine genomics

[ad_1] Is genome editing harder than anyone thought? Will no one weep for Celgene? And is it time to sequence your dog? We discuss all that and more on the...

Read more
LISTEN: FDA furloughs, ’80s pop radio, and video game therapeutics

[ad_1] Is the FDA going broke? Can video games be drugs? And when did “Flashdance” come out? We discuss all that and more on the latest episode of “The Readout...

Read more
LISTEN: A people’s history of J.P. Morgan

[ad_1] Do drug developers tip well? Is biotech safe for 6-year-olds? And what’s a Cable Car Cosmo? We discuss all that and more on this week’s episode of “The Readout LOUD,”...

Read more
LISTEN: Parsing Bristol-Myers-Celgene, grousing about JPM, and how to not be boring

[ad_1] Are megamergers bad for business? Is it time for biotech’s biggest gathering to find a new home? And can a “need” be anything but “unmet”? We discuss all that...

Read more
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

[ad_1] NEW YORK--(BUSINESS WIRE)--Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chief Operating Officer, and Mikael Dolsten, President, Worldwide...

Read more
LISTEN: Watson’s latest stumble, a glimpse into the crystal ball, and revisiting Sarepta

[ad_1] What will become of biotech in 2019? What’s the legacy of Sarepta Therapeutics? And how do you say “overhyped” in Mandarin? We discuss all that and more on the...

Read more
Forget your deepest, darkest secrets, smart speakers will soon listen for sniffles and farts too

[ad_1] All the better to sell you stuff Smart speakers will listen for your farts, yawns and sneezes and analyse it to sell you stuff, a British AI company hopes.…...

Read more
LISTEN: Gilead’s new boss, the year that was, and the thing about DNA tests

[ad_1] Is Gilead Sciences entering a bold new era? What even happened in 2018? And how useful is a genetic credit score? We discuss all that and more on the...

Read more
LISTEN: Using the word ‘cure,’ an FDA loophole, & making biotech history

[ad_1] Can gene therapy cure sickle cell disease? Is an expensive drug better than a free one? And will biotech see its shadow in 2019? We discuss all that and...

Read more
LISTEN: The biggest-ever IPO, drug prices rising in tandem, and burner Twitter accounts

[ad_1] Can unicorns float? Is a hot dog a sandwich? And how are drug companies like gas stations? We discuss all that and more on the latest episode of “The...

Read more
Music To Help You Sleep Better: What To Listen To?

[ad_1] Among the health benefits linked to music, it was unsurprising many also use it to fall asleep faster or more easily. But how do we pick the right soundtrack?...

Read more
Listen: Teen vaping sparks FDA crackdown

[ad_1] Federal regulators want to ban the sale of most flavored e-cigarettes at retail locations like gas stations and convenience stores. Source link [ad_2]

Read more
LISTEN: What the midterms mean, a golden age on hold, and the $4 million drug

[ad_1] Is pharma in for a swarm of subpoenas? Are we running out of ideas in oncology? And can a drug possibly be worth $4 million a dose? We discuss...

Read more
LISTEN: Biotech’s October surprise, the precise cost of precision, and breaking postpartum silence

[ad_1] Why are biotech stocks in the dumps? Is the latest in cancer care overhyped? And what does “folie à deux” mean? We discuss all that and more on the...

Read more
LISTEN: Pharma at the ballot box, the latest Alzheimer’s argument, and truly personalized medicine

[ad_1] Can pharma-shaming get someone re-elected? How rare is too rare when it comes to biotech research? And what does “positive” even mean, really? We discuss all that and more...

Read more